# The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours

> **NCT03863106** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 880 (estimated)

## Conditions studied

- Gastro-enteropancreatic Neuroendocrine Tumor
- Health Care Costs
- Metastatic Cancer

## Interventions

- **OTHER:** Metastatic gastroenteropancreatic and lung neuroendocrine tumors

## Key facts

- **NCT ID:** NCT03863106
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-15
- **Primary completion:** 2019-07
- **Final completion:** 2020-07
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03863106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03863106, "The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03863106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*